Comparison of Oxygen Reserve Index & Regional Cerebral Oxygen Saturation

Status Recruiting

Clinical Trial Summary

The primary aim of this study is to compare the effectiveness of ORI and rcSO2 in predicting hypoxia early in obese patients who are sensitive to hypoxia. Our secondary aim is; To determine whether there is a correlation between the changing trend of ORI and rcSO2 in obese patients.

Clinical Trial Description

Standard noninvasive monitoring will be applied to the patients taken to the operating table, and heart rate, mean arterial pressure, peripheral oxygen saturation (SpO2), oxygen reserve index (ORI), regional cerebral oxygen saturation, etCO2 values will be recorded. Cerebral oximeter probe placed in the middle of the forehead (every second Cerebral oxygen saturation will be continuously monitored using a rcSO2 reading) (Massimo)Preoxygenation will be performed until the expiratory O2 concentration is 90% (during spontaneous ventilation, FIO2 will be kept between 100% 6 lt7min flow rate and EtCO2 30-35 mmHg). 2 mg midazolam, 2 ug General anesthesia with /kg fentanyl, 3 mg/kg propofol, 0.6 mg/kg rocuronium and 100% O2 will be applied and intubated with a videolaryngoscope. The breathing circuit will be disconnected from the endotracheal tube until the SpO2 drops to 94%. At that time, the breathing circuit will be connected and the patients will be ventilated with 100% FiO2, 8 ml kg-1 ideal body weight, targeted tidal volume, and 5 cm H2O positive end-expiratory pressure until the ORI plateaus. Throughout this process, ORI and cerebral oxygen saturation will be recorded continuously. ORI and rcO2 data will be compared at seven specific time points ( (1) during the basal period; (2) at the end of preoxygenation when ORI reaches a plateau; (3) at the beginning of intubation; (4) when SpO2 reaches 97%; (5) when SpO2 reaches 94% (6) ORI reaches a plateau again (during ventilation with 100% FiO2), and (7) SpO2 reaches baseline ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06404151
Study type	Observational
Source	Dr. Lutfi Kirdar Kartal Training and Research Hospital
Contact	Gülten A Arslan, Assos Prof
Phone	05325620366
Email	gulten.arslan@yahoo.com.tr
Status	Recruiting
Phase
Start date	July 1, 2023
Completion date	August 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04597983` - Effect of 8-week Intake of 2S-hesperidin on Performance, Body Composition and Biochemicals Markers in Amateur Cyclists	N/A
Recruiting	`NCT05858463` - High Intensity Interval Training and Muscle Adaptations During PR	N/A
Completed	`NCT03331471` - Alveolar Recruitment Maneuver During Pneumoperitoneum	N/A
Completed	`NCT04626453` - Oxygenation Changes After 2-month Exercise in Sedentary Older Adults With Diabetes	N/A
Enrolling by invitation	`NCT04322994` - THRIVE Use in Pediatric Populations- Multi Site	N/A
Not yet recruiting	`NCT05578131` - High-flow Nasal Cannula for Pediatric Anesthetic Induction	N/A
Completed	`NCT05677009` - Sustainable Preservation of Essential Oxygen Resources: A Phase 4 Crossover Study of the BUFEO System: SAVE O2	N/A
Completed	`NCT04612270` - Quantification of Clinically Relevant Drug Induced Changes in HbO2 Affinity	N/A
Completed	`NCT04584788` - Validation of the O3 Regional Somatic Tissue Oxygenation Monitor	N/A
Recruiting	`NCT04141956` - Incidence of Use of High-Flow Nasal Cannula Oxygen Therapy in Intensive Care Units Patients
Completed	`NCT04973046` - Tissue Oxygen Saturation for Esophagectomy
Terminated	`NCT03665259` - Lower Inspiratory Oxygen Fraction for Preoxygenation	N/A
Recruiting	`NCT03396172` - FreeDom: Innovative Strategy for the Management of COPD Exacerbations	N/A
Completed	`NCT03128372` - Validation of Next Generation Cerebral and Tissue Oximeter	N/A
Completed	`NCT05430724` - The Effects of Nicardipine and Esmolol Applied for Controlled Hypotension	N/A
Recruiting	`NCT05783050` - Wei Nasal Jet Tube vs Nasal Cannula Oxygen Support in Gastrointestinal Endoscopy Patients	N/A
Completed	`NCT04711317` - Pre-oxygenation With High-flow Nasal Cannula in Caesarian Section Under General Anesthesia	N/A
Completed	`NCT03185507` - The Effect of Cryotherapy on Cerebral Hemodynamics Within Healthy Subjects	Phase 1
Completed	`NCT04266665` - Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome	Phase 4
Completed	`NCT06371651` - Creatine and GAA for Brain Oxygenation	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparison of Oxygen Reserve Index and Regional Cerebral Oxygen Saturation Indetermining Hypoxia in Obese Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms